Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J, Hopt UT, Keck T, Stickeler E, Passlick B, Schilling O, Reiss CP, Vashist Y, Brabletz T, Berger J, Lotz J, Olesch J, Werner M, Wellner UF. Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface. J Pathol. 2014;234(3):410–22. https://doi.org/10.1002/path.4416.

Article  PubMed  CAS  Google Scholar 

Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor budding: the name is EMT. Partial EMT. J Clin Med. 2016;5(5): 51. https://doi.org/10.3390/jcm5050051.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704–15. PMID: 18485877; PMCID: PMC2728032.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Modi AP, Nguyen JPT, Wang J, Ahn JS, Libling WA, Klein JM, Mazumder P, Barsky SH. Geometric tumor embolic budding characterizes inflammatory breast cancer. Breast Cancer Res Treat. 2023;197(3):461–78. https://doi.org/10.1007/s10549-022-06819-6.

Article  PubMed  CAS  Google Scholar 

Gotoh O, Sugiyama Y, Takazawa Y, Kato K, Tanaka N, Omatsu K, Takeshima N, Nomura H, Hasegawa K, Fujiwara K, Taki M, Matsumura N, Noda T, Mori S. Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma. Nat Commun. 2019;10(1):4965. https://doi.org/10.1038/s41467-019-12985-x. PMID: 31672974; PMCID: PMC6823358.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Cancer Genome Atlas Research Network, Weinstein JN, Zhang J, Akbani R, Levine DA. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell. 2017;31(3):411–23. https://doi.org/10.1016/j.ccell.2017.02.010.

Article  PubMed  PubMed Central  CAS  Google Scholar 

McKinnon E, Xiao P. Metaplastic carcinoma of the breast. Arch Pathol Lab Med. 2015;139(6):819–22. https://doi.org/10.5858/arpa.2013-0358-RS.

Article  PubMed  CAS  Google Scholar 

Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-Worms H, Chang JC. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020;22(1): 121. https://doi.org/10.1186/s13058-020-01353-z.

Article  PubMed  PubMed Central  Google Scholar 

McCart Reed AE, Kalaw EM, Lakhani SR. An update on the molecular pathology of metaplastic breast cancer. Breast Cancer (Dove Med Press). 2021;13:161–70. PMID: 33664587; PMCID: PMC7924111.

PubMed  CAS  Google Scholar 

McMullen ER, Zoumberos NA, Kleer CG. Metaplastic breast carcinoma: update on histopathology and molecular alterations. Arch Pathol Lab Med. 2019;143(12):1492–6. https://doi.org/10.5858/arpa.2019-0396-RA.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Toy KA, Kleer CG. Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition. Mod Pathol. 2012;25(2):178–84. https://doi.org/10.1038/modpathol.2011.167.

Article  PubMed  CAS  Google Scholar 

Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol. 2010;220(5):562–73. https://doi.org/10.1002/path.2675.

Article  PubMed  CAS  Google Scholar 

Nami B, Ghanaeian A, Black C, Wang Z. Epigenetic silencing of HER2 expression during epithelial-mesenchymal transition leads to trastuzumab resistance in breast cancer. Life (Basel). 2021;11(9): 868. https://doi.org/10.3390/life11090868.

Article  PubMed  CAS  Google Scholar 

Liarte S, Bernabé-García Á, Nicolás FJ. Human skin keratinocytes on sustained TGF-β stimulation reveal partial EMT features and weaken growth arrest responses. Cells. 2020;9(1): 255. https://doi.org/10.3390/cells9010255.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, Zhao J, Zhang HT. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol. 2014;44(5):1643–51. https://doi.org/10.3892/ijo.2014.2310.

Article  PubMed  CAS  Google Scholar 

Wang J, Hoffman RM, Ye Y, Dillard J, Barsky SH. Lymphovascular tumoral emboli in inflammatory breast cancer result from haptotaxis-mediated encircling lymphangiogenesis. Lymphatics. 2024;2(4):195–211. https://doi.org/10.3390/lymphatics2040016.

Article  PubMed  PubMed Central  Google Scholar 

Joshi AS, Sharangpani GM, Porter K, Keyhani S, Morrison C, Basu AS, Gholap GA, Gholap AS, Barsky SH. Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer. Cytometry A. 2007;71(5):273–85. https://doi.org/10.1002/cyto.a.20374. PMID: 17323351.

Article  PubMed  CAS  Google Scholar 

Barsky S, Gentchev L, Basu A, Jimenez R, Boussaid K, Gholap A. Use and validation of epithelial recognition and fields of view algorithms on virtual slides to guide TMA construction. Biotechniques. 2009;47(5):927–38. https://doi.org/10.2144/000113207.

Article  PubMed  CAS  Google Scholar 

Hu L, Ru K, Zhang L, Huang Y, Zhu X, Liu H, Zetterberg A, Cheng T, Miao W. Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine. Biomark Res. 2014;2(1): 3. https://doi.org/10.1186/2050-7771-2-3.

Article  PubMed  PubMed Central  Google Scholar 

Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH. A novel human xenograft model of inflammatory breast cancer. Cancer Res. 1999;59(20):5079–84. PMID: 10537277.

PubMed  CAS  Google Scholar 

Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res. 2001;61(13):5231–41. PMID: 11431364.

PubMed  CAS  Google Scholar 

Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, Goodall GJ, Hadjantonakis AK, Huang RYJ, Kalcheim C, Kalluri R, Kang Y, Khew-Goodall Y, Levine H, Liu J, Longmore GD, Mani SA, Massagué J, Mayor R, McClay D, Mostov KE, Newgreen DF, Nieto MA, Puisieux A, Runyan R, Savagner P, Stanger B, Stemmler MP, Takahashi Y, Takeichi M, Theveneau E, Thiery JP, Thompson EW, Weinberg RA, Williams ED, Xing J, Zhou BP, Sheng G. EMT International Association (TEMTIA). Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341–352. doi: 10.1038/s41580-020-0237-9. Epub 2020 Apr 16. Erratum in: Nat Rev Mol Cell Biol. 2021;22(12):834. https://doi.org/10.1038/s41580-021-00428-9. PMID: 32300252; PMCID: PMC7250738.

Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–8. https://doi.org/10.1172/JCI39104.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15(1): 18. https://doi.org/10.1186/s12943-016-0502-x.

Article  PubMed  PubMed Central  Google Scholar 

Zaravinos A. The regulatoryrrole of MicroRNAs in EMT and cancer. J Oncol. 2015;2015:865816. https://doi.org/10.1155/2015/865816. Epub 2015 Mar 25. PMID: 25883654; PMCID: PMC4389820.

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15(1): 129. https://doi.org/10.1186/s13045-022-01347-8.

Article  PubMed  PubMed Central  Google Scholar 

Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6): 100773. https://doi.org/10.1016/j.tranon.2020.100773.

Article  PubMed  PubMed Central  Google Scholar 

Avigdor BE, Beierl K, Gocke CD, Zabransky DJ, Cravero K, Kyker-Snowman K, Button B, Chu D, Croessmann S, Cochran RL, Connolly RM, Park BH, Wheelan SJ, Cimino-Mathews A. Whole-exome sequencing of metaplastic breast carcinoma indicates monoclonality with associated ductal carcinoma component. Clin Cancer Res. 2017;23(16):4875–84. https://doi.org/10.1158/1078-0432.CCR-17-0108.